[HTML][HTML] Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions

MG Danieli, E Antonelli, S Auria, E Buti… - Autoimmunity Reviews, 2023 - Elsevier
IVIg has been used for a long time as a replacement therapy for primary and secondary
immunodeficiencies. Beside this supplementary role, when used at higher doses (ie, 2 …

[HTML][HTML] Incomplete Kawasaki Disease with Peripheral Facial Nerve Palsy and Lung Nodules: A Case Report and Literature Review

M Maglione, A Barlabà, M Grieco, R Cosimi… - Children, 2023 - mdpi.com
The diagnosis of Kawasaki disease (KD) is challenging and often delayed mainly in case of
young infants and in presence of an incomplete disease and atypical features. Facial nerve …

Cathelicidin (LL‐37) causes expression of inflammatory factors in coronary artery endothelial cells of Kawasaki disease by activating TLR4–NF‐κB–NLRP3 signaling

F Si, Y Lu, Y Wen, T Chen, Y Zhang… - Immunity, Inflammation …, 2023 - Wiley Online Library
Background Kawasaki disease (KD) is a type of vasculitis with an unidentified etiology.
Cathelicidin (LL‐37) may be involved in the development of the KD process; therefore …

Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays

BB Keskin, SF Liu, PX Du, PS Tsai, TS Ho, WY Su… - Analyst, 2023 - pubs.rsc.org
Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly
occurs in children under the age of 5 years. Its etiology has been postulated due to not only …

[HTML][HTML] Epstein–Barr virus downregulates the α7 nicotinic acetylcholine receptor of CD8+ T lymphocytes might associate with coronary artery lesions in Kawasaki …

L Tao, T Zhang, Y Zhou, X Liu, C Ding, J Yu… - Microbes and …, 2023 - Elsevier
Objectives Kawasaki disease (KD) is a systemic vasculitis that is caused by immunological
dysregulation in children exposed to pathogens like Epstein–Barr virus (EBV). Myocardial …

[HTML][HTML] Bibliometric and visual analysis of Kawasaki disease in children from 2012 to 2022

Z Cui, F Luo, J Wang, J Diao, Y Pan - Frontiers in Pediatrics, 2023 - ncbi.nlm.nih.gov
Background In recent years, the incidence of Kawasaki disease among the pediatric
population has experienced a significant increase. With complications mainly affecting the …

The impact of glucocorticoids therapy on cutaneous wounds in Kawasaki disease: A meta‐analysis of randomized controlled trials

J Hu, L Gao, S Fu, W Wang, C Xie… - International Wound …, 2024 - Wiley Online Library
Kawasaki disease (KD) is one of the most challenging diseases that is defined as an acute
vasculitis that affects the coronary arteries primarily in children. It causes complications if left …

Myocardial work is independent risk factor for coronary artery lesions in children with Kawasaki disease

G Tang, X Zheng, K Liu, F Yu, J Zhang - Coronary Artery Disease, 2024 - journals.lww.com
Background The recognition ability of noninvasive echocardiographic myocardial work for
coronary artery lesions (CAL) in children with Kawasaki disease (KD) has not been well …

Protective role of forsythoside B in Kawasaki disease-induced cardiac injury: Inhibition of pyroptosis via the SIRT1–NF-κB–p65 signaling pathway

Y Yang, N Wang, Z Wang, M Zhao, L Chen… - Chemico-Biological …, 2024 - Elsevier
Kawasaki disease (KD), an acute exanthematous febrile pediatric illness involving systemic
non-specific inflammatory reactions in small-and medium-sized arteries, poses a significant …

Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.

H Feng, H Chai, D Li, C Shi, Y Xu… - Alternative Therapies in …, 2024 - search.ebscohost.com
Abstract Background• Kawasaki disease (KD), as one of the most common vascular
diseases in children, will cause the risk of coronary artery lesions (CAL) without treatment …